Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design

Abstract Background Falcipains are major cysteine proteases of Plasmodium falciparum involved in haemoglobin degradation and remain attractive anti-malarial drug targets. Several inhibitors against these proteases have been identified, yet none of them has been approved for malaria treatment. Other...

Full description

Bibliographic Details
Published in:Malaria Journal
Main Authors: Thommas Mutemi Musyoka, Joyce Njoki Njuguna, Özlem Tastan Bishop
Format: Article in Journal/Newspaper
Language:English
Published: BMC 2019
Subjects:
Online Access:https://doi.org/10.1186/s12936-019-2790-2
https://doaj.org/article/ccde157f5b58467493ebbe343bf89440
id ftdoajarticles:oai:doaj.org/article:ccde157f5b58467493ebbe343bf89440
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:ccde157f5b58467493ebbe343bf89440 2023-05-15T15:16:17+02:00 Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design Thommas Mutemi Musyoka Joyce Njoki Njuguna Özlem Tastan Bishop 2019-05-01T00:00:00Z https://doi.org/10.1186/s12936-019-2790-2 https://doaj.org/article/ccde157f5b58467493ebbe343bf89440 EN eng BMC http://link.springer.com/article/10.1186/s12936-019-2790-2 https://doaj.org/toc/1475-2875 doi:10.1186/s12936-019-2790-2 1475-2875 https://doaj.org/article/ccde157f5b58467493ebbe343bf89440 Malaria Journal, Vol 18, Iss 1, Pp 1-21 (2019) Cysteine protease Falcipain Zymogen Prodomain inhibitory segment Homology modelling Binding affinity Arctic medicine. Tropical medicine RC955-962 Infectious and parasitic diseases RC109-216 article 2019 ftdoajarticles https://doi.org/10.1186/s12936-019-2790-2 2022-12-31T09:26:09Z Abstract Background Falcipains are major cysteine proteases of Plasmodium falciparum involved in haemoglobin degradation and remain attractive anti-malarial drug targets. Several inhibitors against these proteases have been identified, yet none of them has been approved for malaria treatment. Other Plasmodium species also possess highly homologous proteins to falcipains. For selective therapeutic targeting, identification of sequence and structure differences with homologous human cathepsins is necessary. The substrate processing activity of these proteins is tightly controlled via a prodomain segment occluding the active site which is chopped under low pH conditions exposing the catalytic site. Current work characterizes these proteases to identify residues mediating the prodomain regulatory function for the design of peptide based anti-malarial inhibitors. Methods Sequence and structure variations between prodomain regions of plasmodial proteins and human cathepsins were determined using in silico approaches. Additionally, evolutionary clustering of these proteins was evaluated using phylogenetic analysis. High quality partial zymogen protein structures were modelled using homology modelling and residue interaction analysis performed between the prodomain segment and mature domain to identify key interacting residues between these two domains. The resulting information was used to determine short peptide sequences which could mimic the inherent regulatory function of the prodomain regions. Through flexible docking, the binding affinity of proposed peptides on the proteins studied was evaluated. Results Sequence, evolutionary and motif analyses showed important differences between plasmodial and human proteins. Residue interaction analysis identified important residues crucial for maintaining prodomain integrity across the different proteins as well as the pro-segment responsible for inhibitory mechanism. Binding affinity of suggested peptides was highly dependent on their residue composition and length. ... Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Malaria Journal 18 1
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic Cysteine protease
Falcipain
Zymogen
Prodomain inhibitory segment
Homology modelling
Binding affinity
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
spellingShingle Cysteine protease
Falcipain
Zymogen
Prodomain inhibitory segment
Homology modelling
Binding affinity
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
Thommas Mutemi Musyoka
Joyce Njoki Njuguna
Özlem Tastan Bishop
Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design
topic_facet Cysteine protease
Falcipain
Zymogen
Prodomain inhibitory segment
Homology modelling
Binding affinity
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
description Abstract Background Falcipains are major cysteine proteases of Plasmodium falciparum involved in haemoglobin degradation and remain attractive anti-malarial drug targets. Several inhibitors against these proteases have been identified, yet none of them has been approved for malaria treatment. Other Plasmodium species also possess highly homologous proteins to falcipains. For selective therapeutic targeting, identification of sequence and structure differences with homologous human cathepsins is necessary. The substrate processing activity of these proteins is tightly controlled via a prodomain segment occluding the active site which is chopped under low pH conditions exposing the catalytic site. Current work characterizes these proteases to identify residues mediating the prodomain regulatory function for the design of peptide based anti-malarial inhibitors. Methods Sequence and structure variations between prodomain regions of plasmodial proteins and human cathepsins were determined using in silico approaches. Additionally, evolutionary clustering of these proteins was evaluated using phylogenetic analysis. High quality partial zymogen protein structures were modelled using homology modelling and residue interaction analysis performed between the prodomain segment and mature domain to identify key interacting residues between these two domains. The resulting information was used to determine short peptide sequences which could mimic the inherent regulatory function of the prodomain regions. Through flexible docking, the binding affinity of proposed peptides on the proteins studied was evaluated. Results Sequence, evolutionary and motif analyses showed important differences between plasmodial and human proteins. Residue interaction analysis identified important residues crucial for maintaining prodomain integrity across the different proteins as well as the pro-segment responsible for inhibitory mechanism. Binding affinity of suggested peptides was highly dependent on their residue composition and length. ...
format Article in Journal/Newspaper
author Thommas Mutemi Musyoka
Joyce Njoki Njuguna
Özlem Tastan Bishop
author_facet Thommas Mutemi Musyoka
Joyce Njoki Njuguna
Özlem Tastan Bishop
author_sort Thommas Mutemi Musyoka
title Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design
title_short Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design
title_full Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design
title_fullStr Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design
title_full_unstemmed Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design
title_sort comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design
publisher BMC
publishDate 2019
url https://doi.org/10.1186/s12936-019-2790-2
https://doaj.org/article/ccde157f5b58467493ebbe343bf89440
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source Malaria Journal, Vol 18, Iss 1, Pp 1-21 (2019)
op_relation http://link.springer.com/article/10.1186/s12936-019-2790-2
https://doaj.org/toc/1475-2875
doi:10.1186/s12936-019-2790-2
1475-2875
https://doaj.org/article/ccde157f5b58467493ebbe343bf89440
op_doi https://doi.org/10.1186/s12936-019-2790-2
container_title Malaria Journal
container_volume 18
container_issue 1
_version_ 1766346570202087424